Farber disease is an inborn lysosomal storage disorder characterized b
y accumulation of ceramide in the patient's tissues due to the deficie
nt activity of acid ceramidase, Currently, confirmation of the diagnos
is is performed in an extremely limited number of laboratories, We the
refore developed a procedure which does not require any particular sph
ingolipid substrate and is based on the quantitation of ceramide level
s in cultured skin fibroblasts, In the method we devised, the ceramide
present in cellular lipid extracts subjected to mild alkaline hydroly
sis was quantified using the commercially available diacylglycerol kin
ase kit. We show that both primary cultures of skin fibroblasts and SV
40-transformed fibroblasts derived from a series of patients with Farb
er disease exhibit ceramide excess as compared to their normal counter
parts (2345-17 153 pmol/mg cell protein in Farber cells vs, 432-1298 p
mol/mg cell protein in controls). Use of this simple method should gre
atly facilitate the biochemical diagnosis of Farber disease.